- A. Health Biotechnology
- Areas of activity
- In vitro diagnostics
- Therapeutic areas
- Genetic and rare diseases
- B. Agrifood Biotechnology
- Agriculture / veterinary / environmental
- Animal health / Veterinary
- D. Services
- R&D services
The company's objective is to contribute to sustainable improvements in heath and well-being, paying special attention to prevention, early diagnosis and treatment of personal healthcare. Having innovative, patented products is a key objective of LETI. The company dedicates to research and development between 8 and 10% of its turnover.
The company is focused in four areas: allergy, dermatolgy, diagnostics, and vaccines.
The Allergy Unit specialises in the production of allergenic extracts for in vivo diagnosis and etiological treatment of allergies. The Dermatology and Personal Healthcare Unit (DPH) is focused on the manufacturing of skincare and other, personal healthcare products. The Diagnostics Unit specialises in in vitro diagnosis and culture media for assisted reproduction. The Vaccine Unit is focused on the development of vaccines for the prevention of leishmaniasis.
Laboratorios LETI is interested in research and development collaborations in the areas of diagnostics, vaccines, and therapies related to allergy, dermatology, immunology and leishmaniasis.
In addition to research and development, the company is interested in expanding access of our products to international markets.